Granules India Ltd is a pharmaceutical company based in India, with a focus on manufacturing active pharmaceutical ingredients and finished dosages. The company is organized into three main areas: Core business, Emerging business, and US Generics. Granules India Ltd operates in various geographic markets including North America, Latin America, Europe, India, and Rest of World. With a Risk Rating Score of 47.3, the company is considered to have a Severe Risk assessment. Granules India Ltd's business model prioritizes sustainability and governance, as reflected in its ESG practices.